Factors Associated with Depression among Type 2 Diabetes Mellitus Patients at a Tertiary Hospital during the COVID-19 Pandemic

Muhammad Ikhsan Mokoagow, Dian Pitawati, Ditya Nona Arisandy, Nadya Magfira, Pratiwi Indah Palupi, Jerry Nasarudin, Marina Epriliawati, Ida Ayu Kshanti


Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia that can cause various complications, economic burdens, and psychosocial issues that eventually lead to depression. This study aimed to describe the prevalence of depression among type 2 diabetes mellitus patients in the Internal Medicine Outpatient Clinic of a South Jakarta tertiary hospital during the COVID-19 pandemic. This cross-sectional study was conducted from May to July 2021. The data were collected consecutively from 100 patients aged 18 years or older who came for regular consultation. The instrument used for determining depression is Beck Depression Inventory-II. The prevalence of depression, a correlation between depression and participants' characteristics, and multivariate analysis for risk factors were determined. The results showed that the prevalence of mild to severe depression based on the BDI-II classification was 17%. Screening showed mild to severe depression predominantly in females above 60 years old, with higher levels of education, obesity grade I, individuals with one or more comorbidities, and those who had diabetes for more than ten years. In this study, having one or more comorbidities was associated with an increased risk of depression in people with diabetes.


Beck Depression Inventory-II; depression screening; diabetes mellitus; prevalence of depression

Full Text:



  1. World Health Organization. Noncommunicable diseases: progress monitor 2020. Geneva: World Health Organization; 2020.

  2. World Health Organization. Noncommunicable diseases country pro-files 2018. Geneva: World Health Organization; 2018.

  3. International Diabetes Federation. IDF diabetes atlas ninth edition 2019. Brussels: International Diabetes Federation; 2019.

  4. Badan Penelitian dan Pengembangan Kesehatan. Hasil utama Riskesdas 2018. Jakarta: Kementerian Kesehatan Republik Indonesia; 2018.

  5. Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes & Endocrinology. 2015; 3 (6): 461-71.

  6. World Health Organization. Depression and other common mental disorders: global health estimates. Geneva: World Health Organization; 2017.

  7. Sartorius N. Depression and diabetes. Dialogues in Clinical Neuroscience. 2018; 20 (1): 47-52.

  8. Pusat Data dan Informasi Kementerian Kesehatan Republik Indonesia. Situasi kesehatan jiwa di Indonesia. Jakarta: Kementerian Kesehatan Republik Indonesia; 2018.

  9. Ettman CK, Abdalla SM, Cohen GH, Sampson L, Vivier PM, Galea S. Prevalence of depression symptoms in US adults before and during COVID-19 pandemic. JAMA Netw Open. 2020; 3 (9): e2019686.

  10. Alessi J, de Oliveira GB, Franco DW, do Amaral BB, Becker AS, Knijnik CP, et al. Mental health in the era of COVID-19: prevalence of psychiatric disorders in a cohort of patients with type 1 and type 2 diabetes during the social distancing. Diabetology & Metabolic Syndrome. 2020; 12: 76.

  11. Ahmed HAS, Fouad AM, Elotla SF, Joudeh AI, Mostafa M, Shah A, et al. Prevalence and associated factors of diabetes distress, depression and anxiety among primary care patients with type 2 diabetes during the COVID-19 pandemic in Egypt: a cross-sectional study. Front Psychiatry. 2022; 13: 937973.

  12. Garcia-Batista ZE, Guerra-Pena K, Cano-Vindel A, Herrera-Martinez XS, Medrano LA. Validity and reliability of the Beck Depression Inventory (BDI-II) in general and hospital population of Dominican Republic. PloS One. 2018; 13 (6): e0199750.

  13. Gebrie MH. An analysis of Beck Depression Inventory 2nd Edition (BDI-II). Glob J Endocrinol Metab. 2018; 2 (3).

  14. Arias-de la Torre J, Vilagut G, Ronaldson A, Serrano-Blanco A, Martin V, Peters M, et al. Prevalence and variability of current depressive disorder in 27 European countries: a population-based study. Lancet Public Health. 2021; 6 (10): e729-38.

  15. Alonso-Moran E, Satylganova A, Orueta JF, Nuno-Solinis R. Prevalence of depression in adults with type 2 diabetes in the Basque Country: relationship with glycaemic control and health care costs. BMC Public Health. 2014; 14: 769.

  16. Idaiani S, Indrawati L. Functional status in relation to depression among elderly individuals in Indonesia: a cross-sectional analysis of the Indonesian National Health Survey 2018 among elderly individuals. BMC Public Health. 2021; 21 (1): 2332.

  17. Chao AM, Wadden TA, Clark JM, Hayden KM, Howard MJ, Johnson KC, et al. Changes in the prevalence of symptoms of depression, loneliness, and insomnia in U.S. older adults with type 2 diabetes during the COVID-19 pandemic: the look AHEAD study. Diabetes Care. 2022; 45 (1): 74-82.

  18. Chauvet-Gelinier JC, Roussot A, Cottenet J, Brindisi MC, Petit JM, Bonin B, et al. Depression and obesity, data from a national administrative database study: geographic evidence for an epidemiological overlap. PLoS One. 2019; 14 (1): e0210507.

  19. Salinero-Fort MA, Gomez Campelo P, San Andres-Rebollo FJ, Cardenas-Valladolid J, Abanades-Herranz JC, de Santa Pau EC, et al. Prevalence of depression in patients with type 2 diabetes mellitus in Spain (The DIADEMA STUDY): results from MADIABETES cohort. BMJ Open 2018; 8 (9): e020768.

  20. Snoek FJ, Bremmer MA, Hermanns N. Constructs of depression and distress in diabetes: time for an appraisal. Lancet Diabetes & Endocrinology. 2015; 3 (6): 450-60.

  21. Darwish L, Beroncal E, Sison MV, Swardfager W. Depression in people with type 2 diabetes: current perspectives. Diabetes Metab Syndr Obes. 2018; 11: 333-43.

  22. Ahmad A, Abujbara M, Jaddou H, Younes NA, Ajlouni K. Anxiety and depression among adult patients with diabetic foot: prevalence of associated factors. J Clin Med Res. 2018; 10 (5): 411-8.

  23. Demmer RT, Gelb S, Suglia SF, Keyes KM, Aiello AE, Colombo PC, et al. Sex differences in the association between depression, anxiety, and type 2 diabetes mellitus. Psychosom Med. 2015; 77 (4): 467-77.

  24. World Health Organization. Regional Office for Europe. Addressing comorbidity between mental disorders and major noncommunicable diseases. Copenhagen: World Health Organization; 2017.

DOI: http://dx.doi.org/10.21109/kesmas.v17i4.6301


  • There are currently no refbacks.